Clinical Trials Logo

Clinical Trial Summary

Heart failure (HF) accounts for 2% of National Health Service (NHS) expenditure, and 5% of emergency hospitalisations. Patients with HF with preserved ejection fraction (HFpEF) are older, have more comorbidities, have similarly poor or worse outcomes compared to patients with reduced ejection fraction (HFrEF), and currently lack an evidence base for treatment. The investigators hypothesise that outcomes of patients with HFpEF can be improved through optimised management and self-management of comorbidities, fluid status and lifestyle delivered in primary care in collaboration with specialists. The primary aim is to develop a programme of optimised management by improving understanding of needs and experiences of patients with HFpEF, clinical decision-making and management in primary care, and integrating research findings with patient and clinical expertise. The main objective for this work package is to identify patients with HFpEF in primary care and assess comorbidities and other factors, management, morbidity and mortality at one year. The methodology employed will be a longitudinal cohort study of 270 patients with HFpEF in primary care followed for 12 months.


Clinical Trial Description

This work package of the study will use phenotyping and one-year follow-up of a community recruited cohort of patients with HFpEF or probable HFpEF to understand the characteristics and needs of this patient group. It involves a longitudinal cohort study conducted to identify patients with HFpEF in primary care and assess comorbidities, lifestyle factors, frailty, self-management, symptoms, quality of life, cognitive function, types of care received, management of risk factors and comorbidities, and one year morbidity and mortality. This will inform particular areas for assessment and management/self-management in the optimised programme. The investigators will also apply to NHS Digital who are the data controllers of Hospital Episode Statistics to check if participants have had any hospitals visits throughout the duration of the study. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03617848
Study type Observational
Source Cambridge University Hospitals NHS Foundation Trust
Contact Christi Deaton, PhD, RN
Phone 01223746607
Email cd531@medschl.cam.ac.uk
Status Recruiting
Phase
Start date July 17, 2018
Completion date June 2021

See also
  Status Clinical Trial Phase
Recruiting NCT01618981 - LEft Atrial Pacing in Diastolic Heart Failure N/A
Completed NCT01726049 - Sildenafil in HFpEF and PH Phase 3
Completed NCT01185067 - Physiological Effects of Grape Seed Extract in Diastolic Heart Failure Phase 1
Completed NCT01091467 - Prospective Study of Heart Failure With Preserved Left Ventricular Ejection Fraction N/A
Recruiting NCT03254485 - A Study of the Effect of IW-1973 on the Exercise Capacity of Patients With Heart Failure With Preserved Ejection Fraction (HFpEF) Phase 2
Recruiting NCT02901184 - Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure With Preserved Ejection Fraction Phase 4
Recruiting NCT01288365 - The Impact of Exercise Training on Functional Capacity in Heart Failure N/A
Not yet recruiting NCT03550235 - Exploration of Dyspnea at Non-high Brain Natriuretic Peptide (BNP)
Active, not recruiting NCT02078947 - Optimizing Exercise Training in Prevention and Treatment of Diastolic Heart Failure N/A
Withdrawn NCT03340233 - Understanding the Mechanisms of Diastolic Dysfunction N/A
Recruiting NCT03226652 - Heart Function in Patients Assessed for Sleep Apnoea N/A
Active, not recruiting NCT01030991 - Classification of Heart Failure With Preserved Ejection Fraction
Completed NCT01411735 - Evaluation of Enalapril Versus Placebo in Patients With Diastolic Heart Failure Phase 3
Active, not recruiting NCT01920711 - Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction Phase 3
Withdrawn NCT03160625 - Evaluation of Rate Adaptive Pacing on Chronotropic Response in Preserved Ejection Fraction HF N/A
Recruiting NCT02053246 - Improving Treatment Personalization of Pulmonary Hypertension Associated With Diastolic Heart Failure Phase 4
Terminated NCT00840463 - Safety and Efficacy Trial to Treat Diastolic Heart Failure Using Ambrisentan Phase 4
Completed NCT00207220 - Ventricular-Vascular Coupling in Heart Failure N/A
Enrolling by invitation NCT03351179 - Predictors and Outcomes of In-hospital HFpEF in AMI Patients N/A
Enrolling by invitation NCT01505179 - The Effects of Ranolazine on Exercise Capacity in Patients With Heart Failure With Preserved Ejection Fraction N/A